Loading market data...

Q Line Biotech IPO

IVD Diagnostics & Medical Devices - Listed on 29 May 2026

+31.8% listing gain
Issue Price (Upper)
Rs 343
Listing Price
Rs 452
Closing Price (NSE)
Rs 474.6
Total Subscription
102.49x

Q Line Biotech IPO listing summary

Q Line Biotech (IVD Diagnostics & Medical Devices) closed its IPO window in 2026 and listed on NSE and BSE on 29 May 2026 at an upper band issue price of Rs 343, opening at Rs 452 for a listing gain of +31.8% and closing day one at Rs 474.6 (+38.4% on closing basis). The IPO was subscribed 102.49x overall - QIB 123.94x, HNI/NII 146.33x, Retail 71.44x. The total issue size was Rs 214.48 Cr (Fresh Issue Rs 214.48 Cr, OFS Rs 0 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+31.78%
Listing Gain (Close)
+38.37%
Day Change After Listing
+5.00%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB123.94x
HNI / NII146.33x
Retail71.44x
Overall102.49x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 14.11x
Day 29.86x
Day 3 (Final)102.49x

Q Line Biotech IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 60+17.49%
Day 2Rs 110+31.78%
Day 3Rs 136+34.99%
Day 4Rs 120+34.99%
Day 5Rs 115+33.53%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
17.5%-35.0%
IPOGyani AI Prediction
-
Actual Listing Gain
+31.8%

Issue & financials

Issue SizeRs 214.48 Cr
Fresh IssueRs 214.48 Cr
OFSRs 0 Cr
IPO PE11.98
Peer / Sector PE32.00
PE vs Sector Ratio0.37
Latest EBITDA (Cr)22.73
Debt / Equity0.87

Market context at listing

How the broader market moved around the Q Line Biotech IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+0.32%
Nifty 1W Return+0.32%
Nifty 1M Return-1.88%
Nifty during IPO window+1.48%

Q Line Biotech IPO - FAQs

What was the listing gain of Q Line Biotech IPO?

Q Line Biotech IPO listed at +31.8% versus the upper issue price of Rs 343 on 29 May 2026.

How many times was Q Line Biotech IPO subscribed?

Q Line Biotech IPO was subscribed 102.49x overall. QIB portion was subscribed 123.94x, HNI / NII 146.33x and Retail 71.44x.

What was the IPO GMP for Q Line Biotech?

IPO GMP started at Rs 60 on Day 1 and moved to Rs 115 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2026

Browse listed IPOs by year